Henry B
Wegovy Quarterly Spend and Utilization Trends While Ozempic drew more attention and total spend, Wegovy represented a significant fiscal burden in its own right, with over $691 million reimbursed across four quarters in 2024
WHERE GLP-1S COME IN Originally developed to treat type 2 diabetes, GLP-1 injections like Ozempic, Wegovy, and Mounjaro have emerged as a beacon of hope for weight loss
Empower Pharmacy is one of the largest and most recognized compounding pharmacies in the United States
In recent years, significant advances have been made in the pharmaceutical field for treating obesity, particularly through Novo Nordisks development of the GLP-1 receptor agonist semaglutide , which has had a major impact and revolutionized treatment
**Various Flavors Available As an Amazon affiliate, GLP-1 Newsroom might earn a commission from a purchase at no extra cost to you